Manufacture

Nominations are now open for The Medicine Maker 2021 Power List.

GlaxoSmithKline has launched a vaccine awareness campaign in the USA as immunization rates drop amidst the pandemic.

Can genomic medicine usher in a new era of curative treatments for neurological diseases? Experts from Sangamo give their views.

A breakthrough in transgenic mice opens the door to “Humabodies.”

How can we achieve gender parity in drug dosing?

We speak with Laertis Ikonomou and Dan Weiss about the ISCT's work to combat unproven cell therapies.

What challenges and opportunities do immunotherapy developers face?

Cell and gene therapies are now considered mainstream therapeutic modalities – with revolutionary potential. But that hasn’t always been the case…

Queenie Jang reveals how the ISCT created an interactive virtual conference in under two months.

Joslin Diabetes Center researchers take the first steps towards an autologous cell therapy for obesity.